| Style | Citing Format |
|---|---|
| MLA | Rezaeimanesh N, et al.. "Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects." Neurological Sciences, vol. 41, no. 9, 2020, pp. 2647-2648. |
| APA | Rezaeimanesh N, Sahraian MA, Moghadasi AN, Eskandarieh S (2020). Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects. Neurological Sciences, 41(9), 2647-2648. |
| Chicago | Rezaeimanesh N, Sahraian MA, Moghadasi AN, Eskandarieh S. "Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects." Neurological Sciences 41, no. 9 (2020): 2647-2648. |
| Harvard | Rezaeimanesh N et al. (2020) 'Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects', Neurological Sciences, 41(9), pp. 2647-2648. |
| Vancouver | Rezaeimanesh N, Sahraian MA, Moghadasi AN, Eskandarieh S. Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects. Neurological Sciences. 2020;41(9):2647-2648. |
| BibTex | @article{ author = {Rezaeimanesh N and Sahraian MA and Moghadasi AN and Eskandarieh S}, title = {Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects}, journal = {Neurological Sciences}, volume = {41}, number = {9}, pages = {2647-2648}, year = {2020} } |
| RIS | TY - JOUR AU - Rezaeimanesh N AU - Sahraian MA AU - Moghadasi AN AU - Eskandarieh S TI - Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects JO - Neurological Sciences VL - 41 IS - 9 SP - 2647 EP - 2648 PY - 2020 ER - |